Journal My Health

08/26/2026

Real-world symptom data is one of the most underused inputs in chronic-condition benefits design.

Most benefits programs are built around claims data — after the fact, after the cost has already landed. Journal My Health takes a different approach: helping individuals build a day-to-day picture of their own patterns, in plain, non-clinical language they can act on immediately.

For employers and health plans evaluating where to invest in chronic-condition support, that's a signal worth paying attention to — a low-cost, low-friction way to help employees self-advocate before symptoms become a bigger (and more expensive) problem.

If you're rethinking what "chronic condition support" looks like for your team, I'd love to compare notes.

08/19/2026

What if the simplest benefit you could offer women navigating menopause and autoimmune symptoms wasn't a new specialist — it was a way to help them advocate for themselves?

Journal My Health isn't a clinical tool, and it's not trying to replace care. It's a wellness platform that helps women build a clear, pattern-based picture of their own health — the kind of specific, day-to-day insight that makes existing medical appointments more productive, faster.

For organizations exploring low-cost, high-impact additions to their benefits mix, this is worth a look: something employees can start using immediately, with no clinical overhead, that directly supports better conversations with the providers they already see.

Open to a short conversation about what a pilot could look like for your team?
Happy to share more.

08/12/2026

Every HR leader is thinking about chronic condition costs. Almost none are thinking about the autoimmune-menopause overlap.

Millions of women in the workforce are navigating both at once — and the symptom overlap makes it harder to identify, harder to manage, and easier to dismiss as "just stress." The result: absenteeism, reduced productivity, and employees who don't have the language to advocate for what they need.

At Journal My Health, we're building tools that help women identify their own patterns — turning "I don't feel right" into something specific enough to act on. That's not just better for the individual. It's a smarter, lower-cost starting point for any organization thinking about chronic-condition support.

Curious what this could look like as part of a benefits conversation? Let's talk.

08/05/2026

A new analysis presented at The Menopause Society's 2025 Annual Meeting looked at nearly 1.8 million postmenopausal women — and found hormone therapy use was linked to a higher incidence of autoimmune disease.

That's a big, unsettling headline for anyone already navigating an autoimmune condition through menopause.

But the study's own lead author, Dr. Xuezhi (Daniel) Jiang of Drexel University College of Medicine, was careful to add context: the actual increase in absolute risk is relatively small and varies by condition, and because it's a retrospective database study, more research is needed before drawing firm conclusions. He was clear that hormone therapy remains a safe and important option for many women when used appropriately.

The throughline from both Dr. Jiang and The Menopause Society's medical director, Dr. Stephanie Faubion: this needs to be individualized. Not a blanket yes or no — a decision based on each woman's own body.

The problem is, most women walk into that conversation with nothing individual to bring. No data on how their body actually responds to sleep, stress, weather, or flares before they even start a new treatment. Just a headline, a worry, and a 15-minute appointment.

That's the gap Journal My Health exists to close. Daily tracking turns "I'm not sure how I'll react" into a real pattern — something specific enough to actually inform an individualized decision, instead of guessing from a population-level study.

Evidence, not guesswork. That's what individualized care requires.

07/29/2026

Apple just put a perimenopause flag inside the default Health app. That's a big deal — not because of what it does, but because of what it signals.

When a platform with roughly a billion active Health app users decides cycle-pattern detection for perimenopause is worth building, it's confirming something the women's health field has been saying for years: this transition has been chronically under-instrumented, and demand for better tools is enormous. Add Midi Health's $100M raise at a $1B valuation this year, and the market signal is unmistakable.

Here's where it gets interesting for us. Apple's feature does what a great consumer platform should do at scale: it notices a pattern shift and nudges you to pay attention. What it isn't built to do — and isn't trying to do — is connect that shift to the layered picture underneath it: autoimmune flares, sleep architecture, weather sensitivity, medication response, all moving together during the transition.

That's the exact population Journal My Health was built for. Apple can tell a woman she may be entering perimenopause. We're building the tools to help her and her clinician understand what that intersection is actually doing to her body — with data detailed enough to inform real treatment decisions, not just awareness.

Big Tech validating the category is a gift for everyone building real infrastructure underneath it. We intend to use it.

07/22/2026

There's a piece in the Times this week making a point worth sitting with: menopause has become a $10B+ market with celebrities, private equity, and philanthropy all leaning in — and yet the actual research investment hasn't caught up.

That gap is the whole story. American medicine has long treated women as pre-pregnant, pregnant, or done — invisible once their reproductive years end. Faced with that silence, women built their own support system: influencers, communal knowledge, folk remedies. Sometimes that works. The piece's writer describes trying a viral tip that succeeded where her doctor never even engaged with the question. That's not a knock on women for going around the system. It's an indictment of the system for leaving them no other option.

But there's a harder truth underneath the consumer boom, and it's the one that should worry anyone building in this space: a cream, a supplement, or a relatable video can generate revenue without generating a single new piece of clinical evidence. The article is blunt about it — the race to sell menopause solutions isn't the same as investing in the research that could change outcomes. And that gap lands hardest on the women least served already: Black and Hispanic women enter menopause earlier and face more complications, yet are documented as least likely to receive medical support for it.

This is exactly the gap Journal My Health was built to close — not with another product to sell, but with data women generate about their own bodies, structured enough to matter clinically. Our Eve Research Project focuses specifically on the intersection of autoimmune disease and menopause, a population with almost no dedicated research behind it, using real daily tracking instead of anecdote.

The menopause revolution is overdue. But revolution has to mean more than a bigger market. It has to mean the evidence finally catches up to the women who've been asking for it for decades.

A new generation is not willing to settle for being invisible.

07/04/2026

This Fourth of July, we celebrate not only our nation's independence but also 250 years of American ingenuity and the people who continue to move us forward.

From breakthroughs in medicine to advances in technology, innovation has always shaped what's possible. At Journal My Health, we're proud to be part of that tradition by helping empower patients, amplify their voices, and transform health data into better care.

As we look ahead, we remain committed to building a future where every individual's health story matters and every data point has the power to improve lives.

From all of us at Journal My Health, we wish you a safe, happy, and meaningful Independence Day.

07/01/2026

Studies show how heat impacts autoimmune flares. It is why we track weather at Journal My Health. Environmental factors play at part in flare ups.

As we enter the dog days of summer, keep cool with lighter colored clothing, staying hydrated, and wearing breathable fabrics.

Read the Study: https://ow.ly/iiqT50ZiR6t

06/02/2026

She managed her lupus for 12 years.

She knew her triggers. Her warning signs. She had a system.

Then perimenopause hit — and everything she knew about her own body stopped working.

New symptoms. Worse flares. Fatigue that felt different. Sleep that wouldn't come. And doctors who kept treating her lupus and her hormones as two completely separate things.

She started tracking with Journal My Health to find her new patterns. Not the ones from 12 years ago — the ones her body was writing right now.

Six weeks in, she had a new map.

If your body has changed and nobody has helped you understand why — this is for you.

Free to download. Link in bio. 💜

05/26/2026

I tracked my symptoms every day for 30 days. Here's what I found out about my own body.

My worst days aren't random. They happen two days after barometric pressure drops. Every single time.

My energy tanks when I sleep less than 6.5 hours. Not 7, not 6. Six and a half.

The week before my period my inflammation spikes. My doctor never connected those two things. The app did.

I'm not a scientist. I just opened an app for 90 seconds a day.

It's called Journal My Health. It's free. Link in bio.